Fluphenazine (Oral) versus placebo for schizophrenia

Schizophrenia Bulletin

Volumn 39, Issue 6, 2013, Pages 1187-1188

  Matar, Hosam E ^a   Almerie, Muhammad Q ^b   Sampson, Stephanie ^c  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Meta analysis; Oral fluphenazine; Schizophrenia; Systematic review

Indexed keywords

FLUPHENAZINE; PLACEBO;

AKATHISIA; ANXIETY; DRUG POTENCY; EXTRAPYRAMIDAL SYMPTOM; FOOD AND DRUG ADMINISTRATION; HUMAN; LONG TERM CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE; REVIEW; SCHIZOPHRENIA;

META- ANALYSIS; ORAL FLUPHENAZINE; SCHIZOPHRENIA; SYSTEMATIC REVIEW;

ANTIPSYCHOTIC AGENTS; FLUPHENAZINE; HUMANS; PLACEBOS; SCHIZOPHRENIA;

EID: 84886072137     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbt140     Document Type: Review

References (1)

1. Matar HE, Almerie MQ, Sampson S. Fluphenazine (oral) versus placebo for schizophrenia. Cochr Database Syst Rev. 2013, Issue 7. Art. No.: CD006352. doi: 10.1002/14651858. CD006352.pub2.